Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance

Take a look inside the London 2014 Congress


Then register to join us
in Barcelona!


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Implantation of toric intraocular lenses to eyes with astigmatism and amblyopia: surprising results

Poster Details

First Author: M.Ilavska SLOVAKIA

Co Author(s):                        

Abstract Details


Clinical evaluation of outcomes of toric hydrophobic intraocular lenses implantations in to the eyes with astigmatism and amblyopia, considered from the young age.


ˡMedilux Eye Centrum, Galanta, Slovak Republic


Cataract surgery was done by incision 2,75 mm, capsulorhexis 5,5 mm, implantation by injector to the capsular bag. The toric intraocular lenses Acrysof Toric SN60T3-T9 ( Alcon, Inc.) were implanted. Spherical equivalent of implanted IOLs was +22.4D, (range +6.0D to +30.0 D). The retrospective evaluation of the astigmatism and visual acuity one week after surgery was done. Statistical analysis was done by Student t-test – comparing of the mean values.


17 patients (25 eyes ) underwent uneventful cataract surgery at period 04/2010 – 02/2015. 8 eyes was considered amblyopic from the young age of great astigmatism or anisometropia. Best corrected visual acuity (BCVA) before surgery was 0.3134 (SD ±0.2556,) (Snellen optotyps). The BCVA after the cataract surgery was 0.7191 (SD± 0.2527). This improving of visual acuity (VA) was significant (p≤0.05). The corneal astigmatism before and after the cataract surgery was unchanged. ( p≥0.05). The BCVA of eyes, which were regarded as amblyopic, had mean value 0.241 (SD ±0.192). The uncorrected VA after surgery was 0.618 (SD ±0.282). This improving was significant p<0.05)


The implantation of toric intraocular lens is a good option for solution of astigmatism at the cataract surgery and significantly improve postoperative uncorrected visual acuity. This procedure may be a viable therapeutic modality for improving visual acuity of eyes with mild and moderate amblyopia at anisometropia.

Financial Disclosure:


Back to Poster listing